News

October: breast cancer awareness month

08 okt, 2018

This article is available in Dutch and French

Evaluating the Current Place of Radiotherapy as Treatment Option for Patients With Muscle Invasive Bladder Cancer in Belgium.

13 Sep, 2018

Source: https://www.ncbi.nlm.nih.gov/pubmed/30190222 There is a gap between optimal and actual use of radiotherapy (RT) in muscle-invasive bladder cancer (MIBC). We investigated the opinions of radiation-oncologists, urologists, and medical oncologists on use of RT in different cases. Barriers and facilitators for applying guidelines were examined.

Characteristics of Radiotherapy Trials Compared With Other Oncological Clinical Trials in the Past 10 Years

29 May, 2018

Source of this article: JAMA network Key Points Question How does a climate of expanding targeted and immune therapies but declining funding from the National Institutes of Health affect the conduct of radiotherapy trials compared with other oncological trials? Findings In a cross-sectional analysis of 25 907 interventional oncological trials registered in ClinicalTrials.gov from 2007 to 2017, only 1378 (5.3%) were radiotherapy trials. Sponsorship or funding for radiotherapy trials was significantly less than that for other oncological studies, and the proportion of radiotherapy trials with a sample size of more than 100 patients has decreased in the past decade. Meaning The decline of radiotherapy trials warrants discussion and collaboration among oncologists, funding agencies, industry leaders, and other concerned parties across multiple geographic regions.

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3)

05 mrt, 2018

Final results of an international, open-label, multicentre, randomised, phase 3 trial

Almost a third of patients that would benefit of radiotherapy do not receive it.

22 Feb, 2018

This article is available in Dutch and French. Discover the Marie Curie legacy here.

New treatment for metastatic prostate cancer

19 Dec, 2017

This article is available in Dutch and French.

Breast Cancer Patients Largely Find Radiation Therapy Experience Better Than Expected

02 okt, 2017

Survey of breast cancer clinic patients finds short- and long-term side effects often better than anticipated; nine in ten women say radiation “less scary” than expected.

The Patient's Perspective on Breast Radiation Therapy: Initial Fears and Expectations Versus Reality

29 Sep, 2017

Presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO). Objective of the study: Breast radiation therapy is associated with misconceptions and fears among patients. Although the efficacy and toxicity of breast radiation has been extensively studied, little is known regarding patient’s perspective on their treatment experience.

Recent Developments in Radiotherapy

28 Sep, 2017

It is estimated that 470,000 patients receive radiotherapy each year in the United States. As many as half of patients with cancer will receive radiotherapy. Improvements in diagnosis, therapy, and supportive care have led to increasing numbers of cancer survivors. In response, the emphasis of radiation oncology has expanded beyond cure to include reducing side effects, particularly late effects, which may substantially affect a patient’s quality of life. Radiotherapy is used to treat benign and malignant diseases and can be used alone or in combination with chemotherapy, surgery, or both. For primary tumors or metastatic deposits, palliative radiotherapy is often used to reduce pain or mass effect (due to spinal cord compression, brain metastases, or airway obstruction). Therapeutic radiation can be delivered from outside the patient, known as external-beam radiation therapy, or EBRT (see the Glossary in the Supplementary Appendix, available with the full text of this article at NEJM.org), by implanting radioactive sources in cavities or tissues (brachytherapy), or through systemic administration of radiopharmaceutical agents. Multiple technological and biologic advances have fundamentally altered the field of radiation oncology since it was last reviewed in the Journal.

Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer

28 Aug, 2017

This article is available in Dutch and French.